Doxycycline vs Durvalumab

Doxycycline vs Durvalumab: Overview

This comparison examines the pharmacological differences between Doxycycline and Durvalumab.

Mechanism of Action

Doxycycline: Inhibits bacterial protein synthesis by binding 30S ribosomal subunit.

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pharmacokinetics

Half-life: Doxycycline — 18-22 hours; Durvalumab — 17 days.

Chemical Properties

Molecular Formula: Doxycycline — C22H24N2O8.

Molecular Weight: Doxycycline — 444.4350 g/mol.

Type: Doxycycline — Small molecule; Durvalumab — Antibody.